AMRN (Amarin Corp Plc) Stock Analysis - AI Report

Amarin Corp Plc (AMRN) is a publicly traded Healthcare sector company. As of May 21, 2026, AMRN trades at $14.16 with a market cap of $294.83M and a P/E ratio of -177.50. AMRN moved +0.00% today. Year to date, AMRN is +5.70%; over the trailing twelve months it is +28.44%. Its 52-week range spans $7.08 to $20.90. Analyst consensus is sell with an average price target of $12.00. Rallies surfaces AMRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on AMRN?

Rallies AI research for AMRN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

AMRN Key Metrics

Key financial metrics for AMRN
MetricValue
Price$14.16
Market Cap$294.83M
P/E Ratio-177.50
EPS$-0.08
Dividend Yield0.00%
52-Week High$20.90
52-Week Low$7.08
Volume209
Avg Volume0
Revenue (TTM)$216.76M
Net Income$-33.61M
Gross Margin52.37%

Latest AMRN News

Recent AMRN Insider Trades

  • Berg Aaron bought 160.00K (~$102.40K) on Aug 2, 2024.

AMRN Analyst Consensus

1 analysts cover AMRN: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $12.00.

Common questions about AMRN

What is the AI research view on AMRN?
Rallies AI research for AMRN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for AMRN?
Rallies AI research for AMRN combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is AMRN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AMRN. It does not provide personalized investment advice.
AMRN

AMRN